Digital Media briefs

Share this article:
Interactivation Health Networks, parent company of hospital and waiting room TV networks The Patient Channel and The Newborn Channel, rebranded as The Wellness Network. The company acquired The Patient Channel and The Newborn Channel from NBC last year.

Pri-Med Point of Care relaunched its website,, adding a blog, regulatory news, company updates and an “Instant proposal tool” allowing clients to submit campaign requests online in minutes and receive back customized proposals.

The New York Times completed its sale of to MDxMedical. UCompareHealthCare promises to help consumers measure the quality of and find healthcare services, healthcare providers and healthcare facilities. MDxMedical said its acquisition of the company, which the Times bought in 2007 to bolster its health vertical, would boost annual visits to its sites to more than 100 million patients.

The Interactive Advertising Bureau announced plans to adopt a code of conduct building on its Self-Regulatory Principles for Online Behavioral Advertising that were adopted by the IAB and other trade groups in 2009.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?